Avastra Sleep Centres

Avastra Sleep Centres (AVS)

Stock Code

AVS

Stock Exchange

ax

Avastra Sleep Centres (AVS) is involved in the biotechnological research and development in the field of wound healing and wound closure. Its main product is biocompatible BioWeld®, a protein-based technology replacing surgical sutures and staples used in the anastomosis (that is, joining) of vessels, like arteries in complex procedures. AVS was listed on the ASX in June 2004. Its head office is situated in North Ryde, Sydney. The company is investigating potential acquisitions in the medical devices area to broaden and lower its technology risk.

Syndicate content

Recommended Websites